Kurs Vortag | 75,66 |
Öffnen | 75,34 |
Gebot | 75,34 x 9000 |
Briefkurs | 75,54 x 30000 |
Tagesspanne | 75,34 - 75,76 |
52-Wochen-Spanne | 71,20 - 89,02 |
Volumen | |
Durchschn. Volumen | 1.152 |
Marktkap. | 100,428B |
Beta (5 J., monatlich) | 0,72 |
Kurs-Gewinn-Verhältnis (roll. Hochrechn.) | 29,72 |
EPS (roll. Hochrechn.) | N/A |
Gewinndatum | N/A |
Erwartete Dividende & Rendite | 2,59 (3,42%) |
Ex-Dividendendatum | 21. Sept. 2023 |
1-Jahres-Kursziel | N/A |
NORTHAMPTON, MA / ACCESSWIRE / November 9, 2022 / Medtronic In this episode, Mira Sahney, president of the Pelvic Health business at Medtronic, explains how incontinence is a debilitating condition that needs more attention and treatment. The company's ...
CECP's CEO Investor Forum, the only platform that brings CEOs and investors together to discuss Long-Term Plans, hosted three CEOs from the world's largest medtech companies-Abbott (NYSE:ABT), Medtronic (NYSE:MDT), and Intuitive Surgical (NASDAQ:ISRG).
Medtronic Stroke is a leading cause of death and disability around the world, but only a fraction of people who suffer a stroke get treatment in time.